10/12/2026
The U.S. Drug Enforcement Administration is closely monitoring the emerging threats of novel synthetic opioids. Illicit drugs have always been dangerous. The emergence of potent synthetic opioids, like cychlorphine, is especially concerning. Drug trafficking organizations frequently modify chemical formulas of known scheduled substances to make their products more potent, more addictive, and more profitable.
In July 2026, DEA published a notice of intent to temporarily schedule cychlorphine as a Schedule I substance, which took effect on August 27, 2026. The temporary scheduling order lasts through August 27, 2028.
Cychlorphine cannot be detected by fentanyl test strips. Naloxone can reverse opioid-related overdoses but, given the potency of cychlorphine, multiple doses may be required. If you suspect someone is experiencing a drug overdose / poisoning, always call emergency services immediately.
